People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Incyclix Bio, LLC | — | Pharmaceuticals | Series A | $26.2M | $35.4M | 2022 |
Sid N. Subramony at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sid N. Subramony on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Fredric N. Eshelman | 1 | 2 |
| Norman N. Sharpless | 1 | 1 |
| Patrick Roberts | 1 | 1 |
| Patrick N. Roberts | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.